Pediatrix Medical Group Inc (MD)

$8.66

+0.2

(+2.36%)

Market is closed - opens 8 PM, 22 Feb 2024

Insights on Pediatrix Medical Group Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 491.00M → 506.61M (in $), with an average increase of 1.6% per quarter

  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, 14.20M → 40.27M (in $), with an average increase of 39.8% per quarter

  • Vs DVA

    In the last 1 year, Davita Healthcare Partners Inc. has given 48.0% return, outperforming this stock by 94.4%

  • Vs HCA

    In the last 3 years, Hca Holdings, Inc. has given 20.5% return, outperforming this stock by 82.0%

Performance

  • $8.35
    $8.90
    $8.66
    downward going graph

    3.58%

    Downside

    Day's Volatility :6.18%

    Upside

    2.7%

    downward going graph
  • $7.70
    $17.02
    $8.66
    downward going graph

    11.09%

    Downside

    52 Weeks Volatility :54.76%

    Upside

    49.12%

    downward going graph

Returns

PeriodPediatrix Medical Group IncSector (Health Care)Index (Russel 2000)
3 Months
-2.98%
11.8%
0.0%
6 Months
-43.03%
8.6%
0.0%
1 Year
-46.35%
11.4%
-6.3%
3 Years
-62.23%
26.9%
-22.0%

Highlights

Market Capitalization
780.6M
Book Value
$11.7
Earnings Per Share (EPS)
1.06
PE Ratio
8.76
PEG Ratio
0.88
Wall Street Target Price
9.86
Profit Margin
4.65%
Operating Margin TTM
7.95%
Return On Assets TTM
4.68%
Return On Equity TTM
9.62%
Revenue TTM
2.0B
Revenue Per Share TTM
24.55
Quarterly Revenue Growth YOY
3.4000000000000004%
Gross Profit TTM
467.0M
EBITDA
210.7M
Diluted Eps TTM
1.06
Quarterly Earnings Growth YOY
-0.31
EPS Estimate Current Year
1.25
EPS Estimate Next Year
1.3
EPS Estimate Current Quarter
0.43
EPS Estimate Next Quarter
0.49

Analyst Recommendation

Sell
    5%Buy
    41%Hold
    52%Sell
Based on 17 Wall street analysts offering stock ratings for Pediatrix Medical Group Inc(by analysts ranked 0 to 5 stars)
Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
2
Hold
7
7
7
Sell
9
9
9

Analyst Forecast

What analysts predicted

Upside of 13.86%

Current $8.66
Target $9.86

Company Financials

FY18Y/Y Change
Revenue
3.6B
↑ 5.46%
Net Income
268.6M
↓ 16.15%
Net Profit Margin
7.37%
↓ 1.89%
FY19Y/Y Change
Revenue
3.5B
↓ 3.66%
Net Income
-1.2B
↓ 528.13%
Net Profit Margin
-32.73%
↓ 40.1%
FY20Y/Y Change
Revenue
1.7B
↓ 50.65%
Net Income
-9.6M
↓ 99.17%
Net Profit Margin
-0.55%
↑ 32.18%
FY21Y/Y Change
Revenue
1.9B
↑ 10.22%
Net Income
131.0M
↓ 1467.06%
Net Profit Margin
6.85%
↑ 7.4%
FY22Y/Y Change
Revenue
2.0B
↑ 3.18%
Net Income
66.3M
↓ 49.35%
Net Profit Margin
3.36%
↓ 3.49%
FY23Y/Y Change
Revenue
2.0B
↑ 2.03%
Net Income
93.5M
↑ 41.01%
Net Profit Margin
4.65%
↑ 1.29%
Q2 FY22Q/Q Change
Revenue
486.0M
↑ 0.79%
Net Income
27.1M
↓ 229.56%
Net Profit Margin
5.58%
↑ 9.92%
Q3 FY22Q/Q Change
Revenue
489.9M
↑ 0.8%
Net Income
30.7M
↑ 13.24%
Net Profit Margin
6.27%
↑ 0.69%
Q4 FY22Q/Q Change
Revenue
513.8M
↑ 4.88%
Net Income
29.7M
↓ 3.48%
Net Profit Margin
5.77%
↓ 0.5%
Q1 FY23Q/Q Change
Revenue
491.0M
↓ 4.44%
Net Income
14.2M
↓ 52.1%
Net Profit Margin
2.89%
↓ 2.88%
Q2 FY23Q/Q Change
Revenue
500.6M
↑ 1.95%
Net Income
28.3M
↑ 99.08%
Net Profit Margin
5.65%
↑ 2.76%
Q3 FY23Q/Q Change
Revenue
506.6M
↑ 1.21%
Net Income
40.3M
↑ 42.4%
Net Profit Margin
7.95%
↑ 2.3%
FY17Y/Y Change
Total Assets
5.9B
↑ 9.89%
Total Liabilities
2.8B
↑ 8.62%
FY18Y/Y Change
Total Assets
5.9B
↑ 1.15%
Total Liabilities
2.8B
↑ 1.65%
FY19Y/Y Change
Total Assets
4.1B
↓ 30.14%
Total Liabilities
2.6B
↓ 7.03%
FY20Y/Y Change
Total Assets
3.3B
↓ 19.25%
Total Liabilities
2.6B
↓ 1.76%
FY21Y/Y Change
Total Assets
2.7B
↓ 18.68%
Total Liabilities
1.8B
↓ 29.78%
FY22Y/Y Change
Total Assets
2.3B
↓ 13.76%
Total Liabilities
1.5B
↓ 20.24%
Q2 FY22Q/Q Change
Total Assets
2.4B
↑ 1.22%
Total Liabilities
1.5B
↑ 4.12%
Q3 FY22Q/Q Change
Total Assets
2.3B
↓ 1.59%
Total Liabilities
1.5B
↓ 3.34%
Q4 FY22Q/Q Change
Total Assets
2.3B
↑ 0.68%
Total Liabilities
1.5B
↓ 1.16%
Q1 FY23Q/Q Change
Total Assets
2.3B
↓ 1.19%
Total Liabilities
1.4B
↓ 3.16%
Q2 FY23Q/Q Change
Total Assets
2.3B
↓ 0.63%
Total Liabilities
1.4B
↓ 3.34%
Q3 FY23Q/Q Change
Total Assets
2.3B
↑ 0.9%
Total Liabilities
1.4B
↓ 0.35%
FY18Y/Y Change
Operating Cash Flow
289.9M
↓ 43.31%
Investing Cash Flow
-142.8M
↓ 75.24%
Financing Cash Flow
-170.6M
↓ 290.12%
FY19Y/Y Change
Operating Cash Flow
346.6M
↑ 19.56%
Investing Cash Flow
102.5M
↓ 171.76%
Financing Cash Flow
-393.1M
↑ 130.39%
FY20Y/Y Change
Operating Cash Flow
204.6M
↓ 40.97%
Investing Cash Flow
815.5M
↑ 695.97%
Financing Cash Flow
-4.2M
↓ 98.94%
FY21Y/Y Change
Operating Cash Flow
76.7M
↓ 62.5%
Investing Cash Flow
-53.1M
↓ 106.51%
Financing Cash Flow
-760.1M
↑ 18180.81%
FY22Y/Y Change
Operating Cash Flow
166.9M
↑ 117.55%
Investing Cash Flow
-57.0M
↑ 7.31%
Financing Cash Flow
-487.6M
↓ 35.86%
Q2 FY22Q/Q Change
Operating Cash Flow
82.4M
↓ 184.54%
Investing Cash Flow
-13.4M
↓ 49.18%
Financing Cash Flow
-62.1M
↓ 75.77%
Q3 FY22Q/Q Change
Operating Cash Flow
83.3M
↑ 1.12%
Investing Cash Flow
-6.1M
↓ 54.4%
Financing Cash Flow
-82.7M
↑ 33.01%
Q4 FY22Q/Q Change
Operating Cash Flow
98.7M
↑ 18.43%
Investing Cash Flow
-11.2M
↑ 84.64%
Financing Cash Flow
-86.3M
↑ 4.39%
Q1 FY23Q/Q Change
Operating Cash Flow
-100.9M
↓ 202.26%
Investing Cash Flow
-11.4M
↑ 0.97%
Financing Cash Flow
108.6M
↓ 225.82%
Q2 FY23Q/Q Change
Operating Cash Flow
89.1M
↓ 188.24%
Investing Cash Flow
-21.7M
↑ 91.61%
Financing Cash Flow
-78.9M
↓ 172.7%
Q3 FY23Q/Q Change
Operating Cash Flow
79.9M
↓ 10.24%
Investing Cash Flow
-35.8M
↑ 64.39%
Financing Cash Flow
-50.6M
↓ 35.89%

Technicals Summary

Sell

Neutral

Buy

Pediatrix Medical Group Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
-11.32%
-43.03%
-46.35%
-62.23%
-76.49%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
4.67%
-14.3%
-0.24%
-42.08%
-48.26%
Hca Holdings, Inc.
Hca Holdings, Inc.
7.03%
12.28%
20.5%
76.51%
117.29%
Universal Health Services Inc.
Universal Health Services Inc.
4.09%
26.6%
9.34%
23.26%
20.72%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
17.56%
20.72%
48.01%
23.02%
107.74%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
8.76
8.76
0.88
1.25
0.1
0.05
NA
11.7
Fresenius Medical Care Ag
Fresenius Medical Care Ag
24.66
24.66
0.84
1.56
0.04
0.02
0.03
47.74
Hca Holdings, Inc.
Hca Holdings, Inc.
16.26
16.26
1.39
20.55
0.12
0.11
0.01
-6.68
Universal Health Services Inc.
Universal Health Services Inc.
17.03
17.03
1.87
10.31
0.11
0.05
0.0
88.85
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
16.47
16.47
1.11
8.94
0.39
0.06
NA
11.89
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pediatrix Medical Group Inc
Pediatrix Medical Group Inc
Sell
$780.6M
-76.49%
8.76
4.65%
Fresenius Medical Care Ag
Fresenius Medical Care Ag
Hold
$12.0B
-48.26%
24.66
2.31%
Hca Holdings, Inc.
Hca Holdings, Inc.
Buy
$81.6B
117.29%
16.26
8.07%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$11.1B
20.72%
17.03
4.82%
Davita Healthcare Partners Inc.
Davita Healthcare Partners Inc.
Hold
$10.7B
107.74%
16.47
5.7%

Institutional Holdings

  • BlackRock Inc

    15.41%
  • Vanguard Group Inc

    12.34%
  • Lazard Asset Management LLC

    9.80%
  • AllianceBernstein L.P.

    9.12%
  • Earnest Partners LLC

    6.07%
  • Dimensional Fund Advisors, Inc.

    5.25%

Company Information

mednax is a physician-led health solutions partner providing the highest quality patient care through our national network of nearly 3,000 physicians. our physician practices and business professionals are passionate about taking great care of patients, continually optimizing performance and helping providers overcome healthcare’s quality, financial and administrative complexities. physicians and advanced practitioners practicing as part of mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research to enhance patient outcomes and provide high-quality, cost-effective care. the company was founded in 1979, and today, through its affiliated professional corporations, mednax provides services through a network of more than 3,200 physicians in all 50 states and puerto rico. in addition to its national physician network, mednax provides services to healthcare facilities and physicians in

Organization
Pediatrix Medical Group Inc
Employees
5250
CEO
Dr. James D. Swift M.D.
Industry
Health Services

FAQs